The updated EBA recommendations provide evidence-based guidance to improve medication safety and reduce errors in anaesthesia and related fields.
Clinicians should adopt updated labeling and reporting protocols to reduce perioperative medication errors; extends prior EBA guidance with current safety standards.
These European Board of Anaesthesiology (EBA) recommendations for safe medication practice replace the first edition of the EBA recommendations published in 2011. They were updated because evidence from critical incident reporting systems continues to show that medication errors remain a major safety issue in anaesthesia, intensive care, emergency medicine and pain medicine, and there is an ongoing need for relevant up-to-date clinical guidance for practising anaesthesiologists. The recommendations are based on evidence wherever possible, with a focus on patient safety, and are primarily aimed at anaesthesiologists practising in Europe, although many will be applicable elsewhere. They emphasise the importance of correct labelling practice and the value of incident reporting so that lessons can be learned, risks reduced and a safety culture developed.
No takes yet. Share an insight, caveat, or question.
Whitaker et al. (2016) conducted a review in Medication errors in anaesthesia, intensive care, emergency medicine and pain medicine. Safe medication practice recommendations was evaluated. The updated European Board of Anaesthesiology recommendations emphasize correct labeling practice and incident reporting to reduce medication errors and develop a safety culture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: